Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

By Akihiko Yoshizawa, N. Motoi, Gregory Riely, C. Sima, W. Gerald, M. Kris, Bernard J Park, V. Rusch, W. Travis. Modern Pathology, 2011

962 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Global Epidemiology of Lung Cancer (2019, background): “This grouping correlates with clinical outcomes, with pre-invasive lesions having an indolent clinical course with almost 100% curability, in contrast to invasive carcinomas, which have a considerably worse prognosis [40].”
Adaptive Weighting Multi-Field-Of-View CNN for Semantic Segmentation in Pathology (2019, methodology): “1Since it is quite difficult for even pathologists to identify Acinar and Papillary [45], we put these two classes into one class.”
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016, background): “Similar to AIS, MIA is usually nonmucinous but rarely may be mucinous or mixed.(2,3,18)”